Lower drug clearance of adalimumab is associated with proactive therapeutic drug monitoring and mucosal healing in patients with inflammatory bowel disease
This study demonstrated that lower ADM clearance is associated with proactive TDM and mucosal healing in patients with IBD.
Authors
- T. Dervieux
- Grace Geeganage
- Ajay Gade (ORCID: https://orcid.org/0000-0001-7259-3579)
- Samantha Zullow
- Adam S. Cheifetz (ORCID: https://orcid.org/0000-0002-6010-1896)
- Laurie B. Grossberg (ORCID: https://orcid.org/0000-0003-3676-868X)
- Mostafa A Soliman (ORCID: https://orcid.org/0000-0003-2689-4455)
- Alessandra Saraga
- L G Rabinowitz
- Konstantinos Papamichael
- Tina Deyhim
Institutions
- Beth Israel Deaconess Medical Center (US)
- Prometheus Biosciences (United States) (US)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1097/meg.0000000000003183
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00